CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV)

CUSIP: 18914F103

Q4 2025 13F Holders as of 31 Dec 2025

Security type / class
Equity / Common Stock
Total 13F shares
126,238,765
Total 13F value
$296,710,184
Holder snapshot 6 visible 7 signals
Share change
-9,433,746
Put/Call ratio
67%
SEC-reported price per share
$2.35
Number of holders
192
Value change
-$28,410,356
Number of buys
84
Open additional details 1 more signal available
Number of sells
93
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
416,598,522

Security key

18914F103

Report period

Q4 2025

Institutions

192

Top holders

10

CLOV full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2026 CLOVER HEALTH INVESTMENTS, CORP. /DE SEC filings CLOVER HEALTH INVESTMENTS, CORP. /DE company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BlackRock, Inc.
Disclosed value leader
BlackRock, Inc.
Comparable rows
1/15
Latest evidence
30 Sep 2025
13F 13D/G 3/4/5 Lead comparable stake: 7.2% 14 rows are not safely comparable across share classes. 13D/G row: BlackRock, Inc. Showing 1-6 of 15 holder rows.

Quick read

BlackRock, Inc. leads the comparable SEC ownership view at 7.2%.

1 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership Top 1
BlackRock, Inc. 7.2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock, Inc.
13F 13D/G
Company
13F 13D/G
7.2%
Reported 13D/G · 30 Jun 2025
$93,008,521
30,394,942 shares
 — 30 Sep 2025
Chamath Palihapitiya
3/4/5
FORMER CHIEF EXECUTIVE OFFICER AND DIRECTOR, 10%+ Owner
3/4/5
—
denominator unverified
$29,544,657
30,147,610 shares
 — 07 Jul 2021
GREENOAKS LLC
3/4/5
Other*, 10%+ Owner
3/4/5
—
denominator unverified
$24,466,828
25,754,556 shares
 — 22 Nov 2021
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$70,563,625
23,060,008 shares
 — 30 Sep 2025
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$29,748,609
9,720,407 shares
 — 30 Sep 2025
STATE STREET CORP
13F
Company
13F
—
denominator unverified
$27,392,129
8,951,676 shares
 — 30 Sep 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
192
Shares
126,238,765
Rows available
192
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
199
Q4 2025 holders
192
Holder diff
-7
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .